Nephrology
News
New eGFR equation ‘less biased’ by age, kidney function; some disagree
The European Kidney Function Consortium equation surpasses existing equations by "resulting in generally lower bias across the spectrum of age and...
Quality
PICC lines often used inappropriately in advanced CKD patients
How common is peripherally inserted central catheter (PICC) use in patients with advanced chronic kidney disease (CKD), and are there associated...
News
Dapagliflozin’s CKD performance sends heart failure messages
The recently reported DAPA-CKD trial results focused on patients with renal disease, but the findings also resonate for heart failure clinicians...
News
DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor use
Until now, SGLT2 inhibitors were for patients with an eGFR of at least 30 mL/min per m2. New evidence moves the threshold down to 25....
News
Deaths sky high in hospitalized COVID patients with kidney injury
“We may be facing an epidemic of post–COVID-19 kidney disease and that, in turn, could mean much greater numbers of patients who require kidney...
News
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes
DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.
News
Real-world data show SGLT2 inhibitors for diabetes triple DKA risk
The findings are based on the use of three different SGLT2 inhibitors in Canada and the United Kingdom.
Clinical
One-year mortality after dialysis initiation nearly double prior estimates
What is the 1-year mortality rate after dialysis initiation in patients older than age 65 years?
Clinical
Canagliflozin protects diabetic kidneys
Do sodium-glucose cotransporter 2 (SGLT2) medications protect at-risk kidneys in type 2 diabetics?
News
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that...